Your browser doesn't support javascript.
loading
Perceptions and Reality of Antimicrobial Prescribing During the Transition to Comfort Measures Only at an Academic Medical Center.
Larnard, Jeffrey; Blackshear, Leslie; Lee, Matthew Shou Lun; Buss, Mary K; Stead, Wendy.
Afiliação
  • Larnard J; Division of Infectious Disease, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
  • Blackshear L; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
  • Lee MSL; Division of Infectious Disease, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
  • Buss MK; Department of Palliative Care, Tufts Medical Center, Boston, Massachusetts, USA.
  • Stead W; Division of Infectious Disease, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Open Forum Infect Dis ; 10(1): ofac692, 2023 Jan.
Article em En | MEDLINE | ID: mdl-36686640
ABSTRACT

Background:

Little is known about antimicrobial prescribing when patient care is transitioned to comfort measures only (CMO). We used a multidisciplinary survey and retrospective cohort study to gain insight into antimicrobial prescribing in this population at an academic medical center to inform future antimicrobial stewardship interventions.

Methods:

A survey focusing on antimicrobial prescribing during the transition to CMO was electronically distributed to providers in medical subspecialities and responses were compared across specialties. A retrospective chart review was performed of patients admitted to an academic medical center in 2020 who were on antimicrobials in the 48 hours prior to CMO. We investigated the percentage of patients who remained on antimicrobials after the transition to CMO and rationale for continuing antimicrobials.

Results:

We received 113 survey responses (35% response rate). Forty-one percent of respondents indicated that they "sometimes" or "often" continued antimicrobials during the transition to CMO. Patient/family preference and symptom palliation were the most common factors cited by respondents when deciding whether to continue antimicrobials in this population. Of the 546 patient charts reviewed, 140 (26%) patients were alive 48 hours after CMO order, and 19 (14%) of those patients remained on antimicrobials. Five of 19 (26%) patients had documentation that antimicrobials were continued due to patient/family preference and 5 of 19 (26%) patients had documentation that antimicrobials were continued for palliation of symptoms.

Conclusions:

Patient/family preference and symptom palliation are important factors in prescribing antimicrobials when patient care is transitioned to CMO. More evidence is needed regarding palliative benefits of antibiotics to inform provider discussions of benefits and harms of antimicrobial use in this setting.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article